The protective effect of hederagenin on renal fibrosis by targeting muscarinic acetylcholine receptor

References

• Akchurin OM. Chronic kidney disease and dietary measures to improve outcomes. Pediatr Clin North Am. 2019;66(1):247–267.
   PubMed Web of Science ®Google Scholar
• Jia Y, Xu H, Yu Q, et al. Identification and verification of vascular cell adhesion protein 1 as an immune-related hub gene associated with the tubulointerstitial injury in diabetic kidney disease. Bioengineered. 2021;12(1):6655–6673.
   PubMed Web of Science ®Google Scholar
• Tu H, Ma D, Luo Y, et al. Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway. Bioengineered. 2021;12(1):6538–6558.
   PubMed Web of Science ®Google Scholar
• Xie Z, Wei L, Chen J, et al. Calcium dobesilate alleviates renal dysfunction and inflammation by targeting nuclear factor kappa B (NF-κB) signaling in sepsis-associated acute kidney injury. Bioengineered. 2022;13(2):2816–2826.
   PubMed Web of Science ®Google Scholar
• Muhammad N, Steele R, Isbell TS, et al. Bitter melon extract inhibits breast cancer growth in preclinical model by inducing autophagic cell death. Oncotarget. 2017;8(39):66226–66236.
   PubMedGoogle Scholar
• Bhattacharya S, Muhammad N, Steele R, et al. Bitter melon enhances natural killer-mediated toxicity against head and neck cancer cells. Cancer Prev Res (Phila). 2017;10(6):337–344.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Muhammad N, Steele R, et al. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth. Oncotarget. 2016;7(22):33202–33209.
   PubMedGoogle Scholar
• Ma W, Huang Q, Xiong G, et al. The protective effect of Hederagenin on pulmonary fibrosis by regulating the Ras/JNK/NFAT4 axis in rats. Biosci Biotechnol Biochem. 2020;84(6):1131–1138.
   PubMed Web of Science ®Google Scholar
• Xu J, Wang X, Zhang H, et al. Synthesis of triterpenoid derivatives and their anti-tumor and anti-hepatic fibrosis activities. Nat Prod Res. 2020;34(6):766–772.
   PubMed Web of Science ®Google Scholar
• Wu R, Dong S, Cai FF, et al. Active compounds derived from fuzheng huayu formula protect hepatic parenchymal cells from apoptosis based on network pharmacology and transcriptomic analysis. Molecules. 2019;24(2): 338.
   Web of Science ®Google Scholar
• Zhou T, Lin W, Lin S, et al. Association of nuclear receptor coactivators with hypoxia-inducible factor-1α in the serum of patients with chronic kidney disease. Biomed Res Int. 2020;2020:1587915.
   PubMed Web of Science ®Google Scholar
• Ma G, Wu X, Zeng L, et al. Association of autoantibodies against M2-muscarinic acetylcholine receptor with atrial fibrosis in atrial fibrillation patients. Cardiol Res Pract. 2019;2019:8271871.
   PubMed Web of Science ®Google Scholar
• Luo L, Xi C, Xu T, et al. Muscarinic receptor mediated signaling pathways in hepatocytes from CCL4 - induced liver fibrotic rat. Eur J Pharmacol. 2017;807:109–116.
   PubMed Web of Science ®Google Scholar
• Chen SF, Lee CL, Kuo HC. Changes in sensory proteins in the bladder urothelium of patients with chronic kidney disease and end-stage renal disease. Low Urin Tract Symptoms. 2019;11(2):O202–O208.
   PubMed Web of Science ®Google Scholar
• Robey RB, Ruiz OS, Baniqued J, et al. SFKs, Ras, and the classic MAPK pathway couple muscarinic receptor activation to increased Na-HCO3 cotransport activity in renal epithelial cells. Am J Physiol Renal Physiol. 2001;280(5):F844–850.
   PubMed Web of Science ®Google Scholar
• Qi R, Yang C. Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury. Cell Death Dis. 2018;9(11):1126.
   PubMed Web of Science ®Google Scholar
• Nogueira A, Pires MJ, Oliveira PA. Pathophysiological mechanisms of renal fibrosis: a review of animal models and therapeutic strategies. In Vivo. 2017;31(1):1–22.
   PubMed Web of Science ®Google Scholar
• Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325–338.
   PubMed Web of Science ®Google Scholar
• Vivarelli M, Massella L, Ruggiero B, et al. Minimal change disease. Clin J Am Soc Nephrol. 2017;12(2):332–345.
   PubMed Web of Science ®Google Scholar
• Gao C, Liu C, Chen Y, et al. Protective effects of natural products against drug-induced nephrotoxicity: a review in recent years. Food Chem Toxicol. 2021;153:112255.
   PubMed Web of Science ®Google Scholar
• Rasmussen DGK, Nielsen PM, Kasab-Oglo OY, et al. A non-invasive biomarker of type III collagen degradation reflects ischaemia reperfusion injury in rats. Nephrol Dial Transplant. 2019;34(8):1301–1309.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhu Z, Wang G, et al. Effects of mycophenolate mofetil on renal interstitial fibrosis after unilateral ureteral obstruction in rats. J Huazhong Univ Sci Technolog Med Sci. 2003;23(3):269–270, 282.
   PubMedGoogle Scholar
• Sun YB, Qu X, Caruana G, et al. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis. Differentiation. 2016;92(3):102–107.
   PubMed Web of Science ®Google Scholar
• Zhang M, Pan X, Zou Q, et al. Notch3 ameliorates cardiac fibrosis after myocardial infarction by inhibiting the TGF-beta1/Smad3 pathway. Cardiovasc Toxicol. 2016;16(4):316–324.
   PubMed Web of Science ®Google Scholar
• Kruse AC, Li J, Hu J, et al. Novel insights into M3 muscarinic acetylcholine receptor physiology and structure. J Mol Neurosci. 2014;53(3):316–323.
   PubMed Web of Science ®Google Scholar
• Zhao L, Chen T, Hang P, et al. Choline attenuates cardiac fibrosis by inhibiting p38MAPK signaling possibly by acting on M3 muscarinic acetylcholine receptor. Front Pharmacol. 2019;10:1386.
   PubMed Web of Science ®Google Scholar
• Khurana S, Jadeja R, Twaddell W, et al. Effects of modulating M3 muscarinic receptor activity on azoxymethane-induced liver injury in mice. Biochem Pharmacol. 2013;86(2):329–338.
   PubMed Web of Science ®Google Scholar
• Kistemaker LE, van Os RP, Dethmers-Ausema A, et al. Muscarinic M3 receptors on structural cells regulate cigarette smoke-induced neutrophilic airway inflammation in mice. Am J Physiol Lung Cell Mol Physiol. 2015;308(1):L96–103.
   PubMed Web of Science ®Google Scholar
• Kang JY, Rhee CK, Kim JS, et al. Effect of tiotropium bromide on airway remodeling in a chronic asthma model. Ann Allergy Asthma Immunol. 2012;109(1):29–35.
   PubMed Web of Science ®Google Scholar
• Pieper MP, Chaudhary NI, Park JE. Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide. Life Sci. 2007;80(24–25):2270–2273.
   PubMed Web of Science ®Google Scholar